Journal Mobile Options
Table of Contents
Vol. 16, No. 6, 1971
Issue release date: 1971
Section title: Pharmacology, Pharmacokinetics, Toxicology
Chemotherapy 1971;16:345–355
(DOI:10.1159/000220749)

Choleretics and Biliary Excretion of Antibiotics in Rats

Coppi G. · Monti L. · Genova R.
Department of Microbiology, Research Laboratories of the ‘Istituto De Angeli’, Milan

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restriction apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Pharmacology, Pharmacokinetics, Toxicology

Published online: 5/19/2009

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 0

ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)

For additional information: http://www.karger.com/CHE

Abstract

αα-Diethyl-1-naphthylacetic acid (DA 808) and α-methyl-α-(2-morpholinoethyl)-1-naphthylacetic acid (DA1627) are compared with dehydrocholic acid for activity on biliary excretion of penicillin G, ampicillin, methicillin, rifamycin SV, tetracycline and demethylchlortetracycline in rats. Unlike to dehydrocholic acid, DA 808 and DA 1627 do not decrease the concentrations of penicillins and tetracycline in the bile. The concentrations of rifamycin SV and demethylchlortetracycline are partially reduced by the two naphthylacetic acid derivatives and markedly reduced by dehydrocholic acid. DA 808 and DA 1627 increase, however, the total amount of the penicillins and tetracycline excreted in the bile but not that of demethylchlortetracycline and rifamycin SV. Dehydrocholic acid does not increase the amount of the antibiotics excreted in the bile. On the basis of these results some remarks of clinical therapy about the association of choleretics-antibiotics in the biliary infections are made.


Article / Publication Details

First-Page Preview
Abstract of Pharmacology, Pharmacokinetics, Toxicology

Published online: 5/19/2009

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 0

ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)

For additional information: http://www.karger.com/CHE


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.